For more than 50 years, ARKRAY has developed innovative diagnostic and monitoring products including automated systems for urinalysis, A1C, clinical chemistry instruments, reagents and consumables. In addition, ARKRAY is a leader in the blood glucose monitoring market with a dominant market share in long term care. ARKRAY continues to evolve and innovate its product lines and programs to meet the changing needs of the industry.
We've been Italy's best known self-care brand for over 50 years. We represent Italian know-how at its best, and are very proud of our national and international reputation. It's all down to the men and women who work on the brand with such passion every day, and above all our commitment to listening to people's needs, observing their behaviour, and using these findings to identify simple solutions to their requirements.
Established in 2016 through the acquisition of Bayer Diabetes Care by PHC Holdings (formerly known as Panasonic Healthcare Holdings), Ascensia Diabetes Care is a global company dedicated to improving the health and lives of people with diabetes. Already including the world‐renowned CONTOUR™ range of blood glucose monitoring systems, we are committed to adding more innovative and life-changing products to our portfolio.
PTS Diagnostics is an innovative point-of-care diagnostics solutions provider that partners with patients and healthcare professionals to provide the right information at the right time to make the right decisions. The company’s name represents the three pillars upon which it has built its long-term success: People, Technology and Service.
With local distributors in 75% of provinces, national distribution partners and Direct to Consumer solutions, we are able to provide quality products to every single customer in every small or large city all across the country.
Through innovative projects, we have managed to team-up with various well-known and internationally recognized partners, to facilitate access to quality products, education and care all across the country.